COMMUNIQUÉS West-GlobeNewswire
-
NANOBIOTIX publiera ses résultats financiers et opérationnels de l'exercice 2023 le 24 avril 2024
17/04/2024 - 22:15 -
NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
17/04/2024 - 22:15 -
Digicann Ventures Announces Agreement to Extend Maturity Date for Convertible Debentures
18/04/2024 - 00:00 -
Hospice Choices: VITAS® Healthcare Opens in Alabama, Expands in Florida Panhandle
17/04/2024 - 19:24 -
ClearPoint Neuro félicite son partenaire AviadoBio pour son premier patient traité dans le cadre de son essai clinique ASPIRE-FTD évaluant l’AVB-101 dans la démence fronto-temporale avec mutations du gène GRN
17/04/2024 - 21:21 -
Change in Leadership at AFB’s Journal of Visual Impairment & Blindness as Longtime Editor in Chief Sandra Lewis Steps Down, Robert Wall Emerson of Western Michigan University to Fill the Role
17/04/2024 - 16:01 -
Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects.
17/04/2024 - 16:15 -
AAMI Releases Guidance on Dilator, Ultrasound DeSterilization
17/04/2024 - 16:51 -
Ipsen publie son Document d’enregistrement universel 2023
17/04/2024 - 18:00 -
Ipsen publishes its 2023 Universal Registration Document
17/04/2024 - 18:00 -
River Oaks Treatment Center is Setting the Standard for Clinical Excellence in Florida with Four Board-Certified Addiction Medicine Physicians
17/04/2024 - 18:45 -
Tilray Brands Lights Up 420 With Music Festivals and Celebrations Across The Country
17/04/2024 - 13:00 -
First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase
17/04/2024 - 13:00 -
Treace to Present at Bank of America Health Care Conference
17/04/2024 - 13:00 -
atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
17/04/2024 - 13:00 -
Elara Caring Partners with Constant Therapy to Deliver First AI-Driven Speech-Language and Cognitive Therapy at Scale
17/04/2024 - 13:05 -
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
17/04/2024 - 13:25 -
Repligen to Report First Quarter 2024 Financial Results
17/04/2024 - 13:30 -
Ocean Drive Plastic Surgery Founder Dr. Alan Durkin Appointed VIO Med Spa Chief Medical Officer
17/04/2024 - 13:48
Pages